INTECH Investment Management’s Amedisys AMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-4,647
Closed -$457K 2408
2025
Q2
$457K Sell
4,647
-2,549
-35% -$241K ﹤0.01% 1646
2025
Q1
$667K Buy
+7,196
New +$663K 0.01% 1457
2024
Q3
Sell
-3,054
Closed -$280K 2016
2024
Q2
$280K Buy
+3,054
New +$283K ﹤0.01% 969

Other funds holding AMED

INTECH Investment Management's AMED Position: Q3 2025 in Review

INTECH Investment Management sold out of Amedisys (AMED) in Q3 2025, closing a stake of 4,647 shares — an estimated $457K sold.

INTECH Investment Management first reported a position in AMED in Q2 2024 and held it in 3 quarters. The position peaked at $667K in Q1 2025. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • INTECH Investment Management reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • INTECH Investment Management sold 4,647 Amedisys shares in Q3 2025, an estimated $457K.
  • INTECH Investment Management first reported a position in Amedisys in Q2 2024 and held it in 3 quarters.
  • INTECH Investment Management's Amedisys position peaked at $667K in Q1 2025.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on INTECH Investment Management's 13F filing for Q3 2025, filed 12 Nov 2025.